Mario Guralnik
Profile
Dr. Mario Guralnik is Head-US Clinical Operations at Ora Bio Ltd.
Dr. Guralnik was previously employed as a Manager-Clinical Affairs by Amgen, Inc.
He received his doctorate degree from the University of California, Los Angeles.
Former positions of Mario Guralnik
| Companies | Position | End |
|---|---|---|
Ora Bio Ltd.
 Ora Bio Ltd. Pharmaceuticals: MajorHealth Technology Ora Bio Ltd. engaged in the repositioning of existing drugs for second-use applications. The firm develops its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration. The company was founded by Yossi Israeli and Amichai Baron in June 2005 and is headquartered in Nazareth Illit, Isreal. | Corporate Officer/Principal | - |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - |
Training of Mario Guralnik
| University of California, Los Angeles | Doctorate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ora Bio Ltd.
Ora Bio Ltd. Pharmaceuticals: MajorHealth Technology Ora Bio Ltd. engaged in the repositioning of existing drugs for second-use applications. The firm develops its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration. The company was founded by Yossi Israeli and Amichai Baron in June 2005 and is headquartered in Nazareth Illit, Isreal. | Health Technology |
- Stock Market
- Insiders
- Mario Guralnik
